The UpSMART Accelerator: driving digital innovation to change the conduct of early phase cancer medicine trials
Butt Fouziah1, Stephenson Laura1, Agnelli Luca2, Villalobos Alberu Xenia3, Carter Louise4, Chown Rachel5, De Braud Filippo6, Damian Silvia2, Dienstmann Rodrigo7, Formica Elisabetta2, Garralda Elena8, Graham Donna M4, Graley Andrew9, Landers Dónal1, O'Regan Paul1, Patil Akshita1, Regan Aoife5, Royle Jennifer K10, Stevenson Julie1, Walker Alison11, Dive Caroline1, Hughes Andrew12
1 Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, United Kingdom 2 Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy 3 Research Coordination Area, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, 115-117, 08035 Barcelona, Spain 4 The Christie NHS Foundation Trust, Manchester; Division of Cancer Sciences, University of Manchester, United Kingdom 5 Cancer Research UK, London, United Kingdom 6 Fondazione IRCCS Istituto Nazionale dei Tumori di Milano; Università Statale di Milano, Milan, Italy 7 Medical Oncology – Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, 115-117, 08035 Barcelona, Spain 8 Medical Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, 115-117, 08035 Barcelona, Spain 9 Microsoft Corporation, Berkshire, United Kingdom 10 Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester; Rekaryo Heath Ltd, West Midlands, United Kingdom 11 The Christie NHS Foundation Trust, Manchester, United Kingdom 12 Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester; Division of Cancer Sciences, University of Manchester, United Kingdom
Correspondence Address:
Butt Fouziah digital Experimental Cancer Medicine Team, Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, Alderley Park, SK10 4TG United Kingdom
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/digm.digm_3_21
|